| Autor: |
Vertrees S; Austin Neurology and Sleep Associates, 711-E1West 38th St, Austin, TX 78705, USA. svertrees@austinneurosleep.com, Greenough GP |
| Jazyk: |
angličtina |
| Zdroj: |
Continuum (Minneapolis, Minn.) [Continuum (Minneap Minn)] 2013 Feb; Vol. 19 (1 Sleep Disorders), pp. 199-203. |
| DOI: |
10.1212/01.CON.0000427223.22963.d4 |
| Abstrakt: |
A patient diagnosed with REM behavior sleep disorder (RBD) has as much as a 65% risk of developing an α-synucleinopathy. Currently, it is not possible to predict whether an individual will develop a disease, or, if so, which disease.The neurologist treating the patient must consider (1) the difference between disclosing a diagnosis and disclosing the risk of a diagnosis; (2) whether to disclose this risk to patients; and (3) if deciding to disclose the risk, the appropriate timing of such a conversation. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
